|
Media Releases |
Financial Reports |
Presen-tations |
|
03/16/2007
|
|
|
|
| Lonza announces personnel change in Investor Relations |
Lonza Group announces the appointment of Alexandre Pasini as Manager of Investor Relations, based in Basel, Switzerland. Alexandre Pasini joins Lonza with many years experience as a senior financial analyst, primarily focused on Swiss equities.
As of 10 April 2007 Alexandre Pasini will manage Investor Relations activities for Lonza, within the Corporate Communications Group, reporting to Margot Connor. Margot Connor will continue to support the Investor Relations activities.
Alex will direct the Investor Relations activities which were previously overseen by Laura Gerber-Wieland.
Please direct your Investor Relations queries to Margot Connor and Alexandre Pasini, as noted below.
Contacts Investor Relations
Investor Relations Lonza Ltd.
Margot Connor
Tel +41 61 316 8566
Fax +41 61 316 9566
Mobile +41 79 401 2832
margot.connor@lonza.com
Investor Relations Lonza Ltd.
Alexandre Pasini
Tel +41 61 316 8835
Fax +41 61 316 9835
alexandre.pasini@lonza.com
Contacts Media Relations
Media Relations Lonza Ltd.
Margot Connor
Tel +41 61 316 8566
Fax +41 61 316 9566
Mobile +41 79 401 2832
margot.connor@lonza.com
Media Relations Lonza Ltd.
Dominik Werner
Tel +41 61 316 8798
Fax +41 61 316 9798
Mobile +41 79 470 6308
dominik.werner@lonza.com
About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of pharmaceutical active ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
Lonza is headquartered in Basel, Switzerland and is listed on the SWX Swiss Exchange. In 2006 Lonza had sales of CHF 2.91 billion. Further information can be found at www.lonza.com.
|
|
|
